Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCOSTEDOAT, Ingrid
dc.contributor.authorMASSON, Maeva
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorDUFFAU, Pierre
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorLAZARO, Estibaliz
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorRICHEZ, Christophe
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorTRUCHETET, Marie Elise
dc.date.accessioned2022-11-15T11:04:02Z
dc.date.available2022-11-15T11:04:02Z
dc.date.issued2021-05-27
dc.identifier.issn0001-5555 (Print) 1651-2057 (Online)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/170263
dc.description.abstractEnThe management of digital ulcers in systemic sclerosis is difficult. While the 2017 European League Against Rheumatism (EULAR) guidelines clearly defined the use of systemic therapies for digital ulcers, little is known about the efficacy of locoregional treatments. The aim of this review is to systematically assess the spectrum of published locoregional therapies for digital ulcers. A total of 58 studies were included. Among the different locoregional treatment strategies descri-bed, injections of fat-derived cells and botulinum toxin showed promising results in the reduction of pain and the number of digital ulcers. By contrast, this review found that sympathectomy yielded disappointing re-sults, with low rates of effectiveness and frequent recurrence. For other treatments, such as hyperbaric oxygen therapy, phototherapy (ultraviolet A), low-level light therapy, intermittent compression, Waon therapy, extracorporeal shockwave, vitamin E gel, and topical dimethyl sulphoxide, the conflicting results or limited published data reflected the low level of evi-dence. Larger randomized clinical trials are required to confirm the validity of promising techniques.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subject.enBotulinum toxin
dc.subject.enDigital ulcers
dc.subject.enFat-derived cells
dc.subject.enSystematic re-view
dc.subject.enSystemic sclerosis
dc.title.enLocoregional treatments for digital ulcers in systemic sclerosis: A systematic review
dc.typeArticle de revueen_US
dc.identifier.doi10.2340/00015555-3839en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed34043013en_US
bordeaux.journalActa Dermato-Venereologicaen_US
bordeaux.volume101en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue6en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03962542
hal.version1
hal.date.transferred2023-01-30T10:40:45Z
hal.exporttrue
dc.rights.ccCC BY-NCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Acta%20Dermato-Venereologica&rft.date=2021-05-27&rft.volume=101&rft.issue=6&rft.eissn=0001-5555%20(Print)%201651-2057%20(Online)&rft.issn=0001-5555%20(Print)%201651-2057%20(Online)&rft.au=COSTEDOAT,%20Ingrid&MASSON,%20Maeva&DUFFAU,%20Pierre&LAZARO,%20Estibaliz&RICHEZ,%20Christophe&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée